104 results found.
          
Orthopedic Sales in Line with Seasonal Expectations for 1Q19
By Mike Evers The first quarter of 2019 brought modest growth to the orthopedic market, as expected seasonal softness and more competition in digital surgery platforms slowed sales for some of the largest players. The 25 companies listed herein had combined total orthopedic sales of $8....
Medicrea Awarded Additional U.S. Patents
Medicrea was allowed three new U.S. patents relating to the company's proprietary UNiD® Adaptive Spine Intelligence software pla...
Medicrea Gains Additional FDA Clearance for Surgical Planning Software
Medicrea enhanced the UNiD ASI (Adaptive Spine Intelligence) platform with addition of a device selection and surgical pla...
Medicrea Reports 1Q19 Revenue of €7.7MM, +10.6% vs. 1Q18
Medicrea reports 1Q19 revenue of €7.7MM (USD $9.5MM), +10.6% vs. 1Q18.
Revenue Review: 4Q18 and Full Year 2018 Performance Highlights for Public Companies
By Mike Evers Below you’ll find a summary of the major 4Q18 and full year 2018 developments for publicly-traded orthopedic companies. Exhibits 1 and 2 show 4Q18 and full year performance, respectively.  Companies continue to refine their strategies to improve sales mix ...
Medicrea Reports 4Q18 Revenue of €8MM, +33.3% vs. 4Q17
Medicrea reports 4Q18 revenue of €8MM (USD $9.9MM), +33.3% vs. 4Q17, with 2018 revenue o...
Revenue Review: 3Q18 Performance Highlights and 2018 Projections for Public Companies, Continued
By Mike Evers In the exhibits below, we've added nine companies to round out our revenue review for 3Q18. As noted in last month's 
Medicrea Reports 3Q18 Revenue of €7.3MM, +14.1% vs. 3Q17
Medicrea reports 3Q18 revenue of €7.3MM (USD $9.0MM), +14.1% vs. 3Q17.
Medicrea Launches Australian Subsidiary
Medicrea entered into a joint venture with National Surgical to offer its products in Australia and New Zealand. ...
Medicrea Gains FDA Clearance for Patient-Specific Spinal Cage
Medicrea obtained what is reported to be the first FDA 510(k) clearance to market patient-specific spinal cages....
Medicrea Forms Direct Sales Subsidiary in Belgium
Medicrea entered into a joint venture with Motion Medical to support direct sales of Medicrea's products in
Hospital for Special Surgery Orders Sectra Orthopaedic 3D Planning Software
Hospital for Special Surgery is investing in 3D pre-op surgical planning software from Sectra to support visual...
The Orthopaedic Products and Services of 2017
By Julie A. Vetalice The annual rundown of products and services is like attending a reunion—we’re looking back over the year and keeping you informed on what everyone is doing. Here’s what made headlines with market entry in 2017. We’ll start with services, and ...
Additive in Orthopaedics in the News: 2017
By Julie A. Vetalice Call it additive or 3D printing, embrace or eschew it, there is no getting around the reality that the technology is a big deal in orthopaedics. What follows is by no means a complete representation of all companies that engage this process, but rather a r...
Medicrea Gains FDA Clearance for 3D-Printed Ti Interbody
Medicrea received FDA 510(k) clearance to market IB3D™ 3D-printed interbody devices, and introduce...
Medicrea Launching UNiD HUB Surgical Planning Software
Medicrea is launching UNiD™ HUB software for spine procedure planning and workflow managemen...
Medicrea Announces First MIS Spine Surgery with Patient-Specific Implants
Medicrea announced completion of the world’s first minimally invasive spine procedure using patient-specific implant...
1H17 Funding Recap: Investors Continue to Back Regulatory-Approved Orthopaedic Technologies
The 24 funding announcements we tracked by orthopaedic companies in 1H17 kept pace with the number of announcements made in the first halves of 2016 and 2015, signaling that the environment to raise capital remains consistent, but difficult. Risk-adverse private equity, venture capital and other ...
Public and Private Company Revenue Review: 1Q17
By Julie A. Vetalice We're eager to see 2Q17 results to prepare a 1H review for you. In the interim, here are the 1Q17 numbers for publicly-traded companies, with updates and estimates for a number of privately-traded companies, too. Exhibits 1 and 2 illustrate 1Q17 performanc...
Medicrea Raises €13MM Through Private Placement
Medicrea raised €13.0MM (~US $14.5MM) in a private placement. Funds will support development of the UNiD&tr...
Medicrea Receives FDA Clearance for UNiD HUB Digital Portal
Medicrea received FDA 510(k) clearance for UNiD™ HUB, a data-driven digital portal that employs...
Medicrea Announces FDA Clearance of PASS TULIP Top-Loading Spinal Fixation
Medicrea received FDA 510(k) clearance and performed first surgeries with PASS® TULIP...
Orthopaedic Pediatric Market Draws New Companies, Products
By Carolyn LaWell EPOSNA 2017, the combined annual meeting of the European Paediatric Orthopaedic Society and Pediatric Orthopaedic Society of North America, served as an unveiling for new products, brands and companies as a focus on this niche market is drawing in device companies....
Orthofix Launches JuniOrtho Pediatric Orthopaedic Brand
Orthofix launched JuniOrtho™, a new brand to address products and services that treat pediatric orthopaed...
Medicrea 1Q17 Revenue
Medicrea posted 1Q17 revenue of €7.0MM (~US $7.5MM), -6.3% vs. 1Q16. 
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group